Sensei Biotherapeutics, Inc. (SNSE) SEC Filings — 2024
23 SEC filings for Sensei Biotherapeutics, Inc. (SNSE) in 2024.
Filings
- Sensei Biotherapeutics Files 8-K on Financials — 8-K · Nov 14, 2024
- Sensei Biotherapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Sensei Biotherapeutics: Leadership Changes and New Board Member — 8-K · Oct 30, 2024
- Sensei Biotherapeutics Appoints New CMO and Director — 8-K · Sep 20, 2024
- Sensei Biotherapeutics Files 8-K on Financials — 8-K · Aug 6, 2024
- Sensei Biotherapeutics Files Q2 2024 10-Q — 10-Q · Aug 6, 2024
- Sensei Biotherapeutics Faces Nasdaq Delisting Warning — 8-K · Jul 12, 2024
- Sensei Biotherapeutics Adds Oncology Expert to Board — 8-K · Jun 27, 2024
- Sensei Biotherapeutics Reports Shareholder Vote Matters — 8-K · Jun 13, 2024
- Sensei Biotherapeutics Files 8-K — 8-K · Jun 3, 2024
- Intellia Therapeutics to Acquire Sensei Biotherapeutics for $300M — 8-K · May 23, 2024
- Sensei Biotherapeutics Files 8-K on Financials — 8-K · May 9, 2024
- Sensei Biotherapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Sensei Biotherapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- Sensei Biotherapeutics Appoints New CMO, CEO Employment Agreement — 8-K · Apr 12, 2024
- Sensei Biotherapeutics Appoints New CMO, Director — 8-K · Apr 2, 2024
- Newtyn Management Amends Sensei Biotherapeutics Stake — SC 13D/A · Mar 7, 2024
- Sensei Biotherapeutics Files 8-K: Material Agreements & Security Holder Rights — 8-K · Mar 5, 2024
- Sensei Biotherapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- Sensei Biotherapeutics Relocates HQ, Updates Financials — 8-K · Feb 28, 2024
- Newtyn Management Amends Sensei Biotherapeutics Stake — SC 13D/A · Feb 13, 2024
- Sensei Biotherapeutics Reports Officer Compensation, Director Changes — 8-K · Feb 8, 2024
- Sensei Biotherapeutics Confirms Nasdaq Listing for Common & Preferred Stock — 8-K · Jan 4, 2024